Overexpression of transforming growth factor-β1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy

Circulation

Volumn 96, Issue 3, 1997, Pages 874-881

  Li, Ren Ke ^a,c   Li, Guangming ^a   Mickle, Donald A G ^a   Weisel, Richard D ^a   Merante, Frank ^a   Luss, Hartmut ^b   Rao, Vivek ^a   Christakis, George T ^a   Williams, William G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cardiomyopathy; Growth substances; Hypertrophy; Immunohistochemistry; Molecular biology

Indexed keywords

ANTIBODY; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH FACTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030877545     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.874     Document Type: Article

References (36)

1. Elstein E, Leiw C-C, Sole MJ. The genetic basis of hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1992;24:1471-1477.
2. Hengstenberg C, Schwartz K. Molecular genetics of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1994;26:3-10.
3. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;75:701-712.
4. Watkins H, Seidman CE, MacRae C, Seidman JG, McKenna W. Progress in familial hypertrophic cardiomyopathy: molecular genetic analysis in the original family studies by Teare. Br Heart J. 1992;67:34-38.
5. Gilligan DM, Cleland JGF, Oakley CM. The genetics of hypertrophic cardiomyopathy. Br Heart J. 1991;66:193-195.
6. Golf S, Myhre E, Abdelnoor M, Andersen D, Hansson V. Hypertrophic cardiomyopathy characterized by beta-andrenoceptor density, relative amount of beta-adrenoceptor subtypes and adenylate cyclase activity. Cardiovasc Res. 1985;19:693-699.
7. Wagner JA, Sax FL, Weisman HF, Porterfied J. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med. 1989;320:755-761.
8. Kardami E. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem. 1990;92:129-135.
9. Soonpaa MH, Oberpriller JO, Oberpriller JC. Stimulation of DNA synthesis by PDGF in the newt cardiac myocyte. J Mol Cell Cardiol. 1992;24:1039-1046.
10. Villarrel FJ, Lee AA, Dillmann WH, Giordano FJ. Adenovirus-mediated overexpression of human transforming growth factor-β1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J Mol Cell Cardiol. 1996;28:735-742.
11. Hanson MC, Fath KA, Alexander RW, Delafontaine P. Induction of cardiac insulin-like growth factor I gene expression in pressure overload hypertrophy. Am J Med Sci. 1993;306:69-74.
12. Padua R, Kardami E. Increased basic fibroblast growth factor accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury. Growth Factor. 1993;8:291-306.
13. Takahashi N, Calderone A, Izzo NJ Jr, Maki TM, Marsh JD, Colucci WS. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular cardiomyocytes. J Clin Invest. 1994;94:1470-1476.
14. Villarrel FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol. 1992;262:H1861-H1866.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989:14.5-14.20.
16. Zerbini M, Musiani M, Gibellini D, Gentilomi G, Venturoli S, Gallinella G, La Placa M. Evaluation of strand-specific RNA probes visualized by colorimetric and chemiluminescent reactions for the detection of B19 parvovirus DNA. J Virol Meth. 1993;45: 169-178.
17. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol. 1981;75:816-821.
18. Bjarnason I, Jonsson S, Hardarson T. Mode of inheritance of hypertrophic cardiomyopathy in Iceland: echocardiographic study. Br Heart J. 1982;47:122-129.
19. Codd MB, Sugrue DD, Gersh BJ, Melton CJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population-study of Olmsted county, Minnesota, 1975-1984. Circulation. 1989;80:564-572.
20. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749-755.
21. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995; 92:1680-1692.
22. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979;43:1242-1244.
23. Maron BJ, Roberts WC. Hypertrophic cardiomyopathy. In: Schlant RC, Alexander RW, eds. The Heart: Arteries and Veins. 8th ed. New York, NY: McGraw-Hill Health Professions Division; 1994: 1621-1635.
24. Factor SM, Butany J, Sole MJ, Wigle D, Williams WC, Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1991;17:1343-1351.
25. Engelman GL, Boehm KD, Haskell JF, Khairallah PA, Ilan J. Insulin-like growth factors and neonatal cardiomyocyte development: ventricular gene expression and membrane receptor variations in hormotensive and hypertensive rats. Mol Cell Endocrinol. 1989;63:1-14.
26. Reiss K, Kajstura J, Capasso JM, Marino TM, Anversa P. Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF-1 autocrine system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic division in rats. Exp Cell Res. 1994;207:348-360.
27. Toyozaki T, Hiroe M, Hasumi M, Hosoda S, Tsushima T, Sekiguchi M. Insulin-like growth factor I receptors in human cardiac myocytes and their relation to myocardial hypertrophy. Jpn Circ J. 1993;57: 1120-1127.
28. Decker RS, Cook MG, Behnke-Barclay M, Decker ML. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading. Circ Res. 1995; 77:544-555.
29. Adachi S, Ito H, Akimoto H, Tanaka M, Fujisaki H, Marumo F, Hiroe M. Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes. J Mol Cell Cardiol. 1994;26:789-795.
30. Fuller SJ, Mynett JR, Sugden PH. Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochem J. 1992;282:85-90.
31. Ito H, Hiroe M, Hirara Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-1721.
32. Diez J, Laviades C. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. J Hypertens. 1994;12:s31-s36.
33. Amato G, Carella C, Fazio S, Montagna GL. Cittadini A, Sabatini D, Mariano-Mone C, Sacca L, Bellastella A. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low dose. J Clin Emlocrinol Metab. 1993;77:1671-1676.
34. Pricci F, Pugliese G, Romano G, Romeo G, Locuratolo N, Pugliese F, Mene P, Galli G, Casini A, Rotella CM, Mario UD. Insulin-like growth factor I and II stimulate extracellular matrix production in human glomerular mesangial cells: comparison with transforming growth factor-beta. Endocrinology: 1996;137:879-885.
35. Sakata Y. Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue. Hokkaido Igaku Zasshi-Hokkaido J Med Sci. 1993;68:18-28.
36. Eghbali M, Tomek R, Woods C, Bhambi B. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor β. Proc Nail Acad Sci U S A. 1991;88: 795-799.